Novel hybrids of podophyllotoxin and formononetin inhibit the growth, migration and invasion of lung cancer cells

被引:24
作者
Yang, Chengli [1 ]
Xie, Qiongli [1 ]
Zeng, Xian [1 ]
Tao, Nengyin [1 ]
Xu, Yingshu [1 ]
Chen, Yongzheng [1 ]
Wang, Jing [1 ]
Zhang, Lei [1 ]
机构
[1] Zunyi Med Univ, Sch Pharm, Green Pharmaceut Engn Res Ctr Guizhou Prov, Gener Drug Res Ctr Guizhou Prov, Zunyi 563003, Peoples R China
基金
中国国家自然科学基金;
关键词
Podophyllotoxin; Formononetin; Hybridization; Antiproliferative activity; Migration; Invasion; BIOLOGICAL EVALUATION; TUMOR-GROWTH; DERIVATIVES; DESIGN; VIMENTIN; SUPPRESSES; EXPRESSION; ANALOGS;
D O I
10.1016/j.bioorg.2019.02.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, three hybrids of podophyllotoxin and formononetin were synthesized and evaluated for anticancer efficacy. Some of the derivatives exhibited potent cytotoxicity against a panel of human and mouse cancer cell lines, with IC50 values in the low micromolar to submicromolar range. Evaluation against A549 lung tumor cell line identified that the IC50 value of compound 10a was 0.753 mu M, indicating that 10a was 2.568-fold more efficacious than parent podophyllotoxin. Mechanistic studies revealed that 10a induced A549 cell apoptosis mainly via caspase pathway, as well as disrupted the microtubule organization by occupying the colchicine binding site of the tubulin. Moreover, wound healing assay and transwell invasion assay indicated that 10a displayed potent inhibitory effects on invasion and migration in A549 cancer cells. In additiona, a decrease in vimentin immunostaining was also observed in A549 cells after treatment with 10a. Overall, hybrid 10a might be a promising candidate for the potential treatment of human lung carcinoma.
引用
收藏
页码:445 / 454
页数:10
相关论文
共 40 条
  • [1] Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy
    Bailly, Christian
    [J]. CHEMICAL REVIEWS, 2012, 112 (07) : 3611 - 3640
  • [2] Cancer Statistics in China, 2015
    Chen, Wanqing
    Zheng, Rongshou
    Baade, Peter D.
    Zhang, Siwei
    Zeng, Hongmei
    Bray, Freddie
    Jemal, Ahmedin
    Yu, Xue Qin
    He, Jie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) : 115 - 132
  • [3] Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas
    Dauphin, Maryline
    Barbe, Coralie
    Lemaire, Sarah
    Nawrocki-Raby, Beatrice
    Lagonotte, Eymeric
    Delepine, Gonzague
    Birembaut, Philippe
    Gilles, Christine
    Polette, Myriam
    [J]. LUNG CANCER, 2013, 81 (01) : 117 - 122
  • [4] Formononetin inhibits neuroinflammation and increases estrogen receptor beta (ERβ) protein expression in BV2 microglia
    El-Bakoush, Abdelmeniem
    Olajide, Olumayokun A.
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 61 : 325 - 337
  • [5] Tumour-cell invasion and migration: Diversity and escape mechanisms
    Friedl, P
    Wolf, K
    [J]. NATURE REVIEWS CANCER, 2003, 3 (05) : 362 - 374
  • [6] Design and synthesis of formononetin-dithiocarbamate hybrids that inhibit growth and migration of PC-3 cells via MAPK/Wnt signaling pathways
    Fu, Dong-Jun
    Zhang, Li
    Song, Jian
    Mao, Ruo-Wang
    Zhao, Ruo-Han
    Liu, Ying-Chao
    Hou, Yu-Hui
    Li, Jia-Huan
    Yang, Jia-Jia
    Jin, Cheng-Yun
    Li, Ping
    Zi, Xiao-Lin
    Liu, Hong-Min
    Zhang, Sai-Yang
    Zhang, Yan-Bing
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 127 : 87 - 99
  • [7] Cost of migration: Invasion of malignant gliomas and implications for treatment
    Giese, A
    Bjerkvig, R
    Berens, ME
    Westphal, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) : 1624 - 1636
  • [8] Podophyllotoxin:: distribution, sources, applications and new cytotoxic derivatives
    Gordaliza, M
    García, PA
    del Corral, JMM
    Castro, MA
    Gómez-Zurita, MA
    [J]. TOXICON, 2004, 44 (04) : 441 - 459
  • [9] Antitumor properties of podophyllotoxin and related compounds
    Gordaliza, M
    Castro, MA
    del Corral, JMM
    San Feliciano, A
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (18) : 1811 - 1839
  • [10] Guo YuDong Guo YuDong, 2011, China Journal of Traditional Chinese Medicine and Pharmacy, V26, P560